Final rule 2026-10898
Medical Devices; Hematology and Pathology Devices; Classification of the Von Willebrand Factor Assay
The Food and Drug Administration (FDA) is classifying the von Willebrand factor assay into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the von Willebrand factor assay. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-10898
- Published
- Jun 1, 2026
- Effective
- Jun 1, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 32336
Docket identifiers
- Docket No. FDA-2026-N-5725
CFR references
- Title 21, part 864